CAG repeat number governs the development rate of pathology in huntington's disease

Annals of Neurology

Volumn 41, Issue 5, 1997, Pages 689-692

  Penney Jr , John B ^a   Vonsattel, Jean Paul ^a   MacDonald, Marcy E ^a   Gusella, James F ^a   Myers, Richard H ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HUNTINGTIN;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; DEGENERATIVE DISEASE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; NERVE CELL NECROSIS; NEUROPATHOLOGY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; HUMANS; HUNTINGTON DISEASE; MIDDLE AGED; SURVIVAL ANALYSIS; TRINUCLEOTIDE REPEATS;

EID: 0030919726     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410521     Document Type: Article

References (23)

1. Gusella JF, MacDonald ME. Huntington's disease: CAG genetics expands neurobiology. Curr Opin Neurobiol 1995;5:656-662
2. Paulson HL, Fischbeck KH. Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 1996;19:79-107
3. Persichetti F, Srinidhi J, Kanaley L, et al. Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains. Neurobiol Dis 1994;1:159-166
4. Illarioshkin SN, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann Neurol 1994;36:630-635
5. Brandt J, Bylsma FW, Gross R, et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996;46:527-531
6. Kieburtz K, MacDonald M, Shih C, et al. Trinucleotide repeat length and progression of illness in Huntington's disease. J Med Genet 1994;31:872-874
7. Furtado S, Suchowersky O, Rewcasle NB, et al. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 1996;39:132-136
8. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577
9. Warner JP, Barron LH, Brock DJH. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 1993;7:235-239
10. Myers RH, Vonsattel JP, Paskevich PA, et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991;50: 729-742
11. Myers RH, Vonsattel JP, Stevens TJ, et al. Clinical and neuropathological assessment of severity in Huntington's disease. Neurology 1988;38:341-347
12. Grafton ST, Mazziotta JC, Pahl JJ, et al. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Ann Neurol 1990;28: 614-621
13. Hayden M, Hewitt J, Stoessl A, et al. The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease. Neurology 1987; 37:1441-1447
14. Wexler NS. Perceptual-motor, cognitive, and emotional characteristics of persons at-risk for Huntington's disease. Adv Neurol 1979;1:257-271
15. Diamond R, White RF, Myers RH, et al. Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol 1992;14:961-975
16. Young AB, Penney JB, Markel DS, et al. Genetic linkage analysis, glucose metabolism and neurologic examination: comparison in persons at risk for Huntington's disease (HD). Neurology 1988;38(suppl 1):359
17. Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Arch Neurol 1983;40:791-796
18. Rothlind JC, Brandt J, Zee D, et al. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease. Arch Neurol 1993;50: 799-802
19. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-157
20. Li XJ, Li SH, Sharp AH, et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995;378:398-402
21. Burke JR, Enghild JJ, Martin ME, et al. Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2:347-350
22. Bao J, Sharp AH, Wagster MV, et al. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 1996;93: 5037-5042
23. Goldberg YP, Nicholson DW, Rasper DM, et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 1996;13: 442-449